Ciprofloxacin ophthalmic solution USP, 0.3% as base, package in bottles: a) 10 mL (NDC 69315-308-...

FDA Recall #D-0623-2024 — Class II — July 23, 2024

Recall #D-0623-2024 Date: July 23, 2024 Classification: Class II Status: Ongoing

Product Description

Ciprofloxacin ophthalmic solution USP, 0.3% as base, package in bottles: a) 10 mL (NDC 69315-308-10), b) 2.5 mL (NDC 69315-308-02), Rx Only, Distributed by: Leading Pharma LLC, Fairfield, NJ. Manufactured by: FDC Limited, Maharashtra, India.

Reason for Recall

Defective container: unable to get the solution out of the bottle as the spike of the cap was lodged in the nozzle of the product bottle.

Recalling Firm

FDC Limited — Aurangabad, Maharashtra State, N/A

Classification

Class II — May cause temporary or medically reversible adverse health consequences.

Product Type

Drugs

Product Quantity

66,528 bottles

Distribution

U.S. A. Nationwide

Code Information

Lot#: a) 084C040, Exp 02/28/2026; b) 084A024, Exp12/31/2025.

Status

Ongoing

Voluntary / Mandated

Voluntary: Firm initiated